This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Mar 1;27(7):1005-6.

doi: 10.1200/JCO.2008.20.4057. Epub 2009 Jan 26.

Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy

Alexander Paterson, Tom Baker

PMID: 19171701
DOI: 10.1200/JCO.2008.20.4057

Editorial

Bisphosphonates and bone turnover in premenopausal women receiving adjuvant chemotherapy

Alexander Paterson et al. J Clin Oncol. 2009.

. 2009 Mar 1;27(7):1005-6.

doi: 10.1200/JCO.2008.20.4057. Epub 2009 Jan 26.

Authors

Alexander Paterson, Tom Baker

PMID: 19171701
DOI: 10.1200/JCO.2008.20.4057

No abstract available

PubMed Disclaimer

Comment on

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.
Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Hines SL, et al. J Clin Oncol. 2009 Mar 1;27(7):1047-53. doi: 10.1200/JCO.2008.19.1783. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075260 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information